Jensen, Jesper http://orcid.org/0000-0003-2821-9947
Omar, Massar
Kistorp, Caroline
Poulsen, Mikael Kjær
Tuxen, Christian
Gustafsson, Ida
Køber, Lars
Gustafsson, Finn
Fosbøl, Emil
Bruun, Niels Eske
Videbæk, Lars
Frederiksen, Peter Hartmund
Møller, Jacob Eifer
Schou, Morten
Funding for this research was provided by:
the Research Council at Herlev-Gentofte Hospital (-)
FUKAP at the Department of Cardiology at Herlev-Gentofte Hospital (-)
the Capital Region of Denmark (A6058)
the Danish Heart Foundation (17-R116-A7714-22076, 18-R124-A8573-22107)
the A.P. Møller Foundation for the Advancement of Medical Science (journal number 17-L-0002)
Article History
Received: 9 January 2019
Accepted: 27 May 2019
First Online: 21 June 2019
Ethics approval and consent to participate
: All patients give written informed consent before enrolment. The trial, including the consent form and all other related documentation given to patients, is approved by the Regional Committee on Health Research Ethics, Capital Region of Denmark (reference number H-17010756).
: Not applicable.
: JJ, MO, CK, MKP, CT, IG, LK, EF, NEB, LV, PHF, and JEM declare no conflicts of interest. FG reports lecture fee from Boehringer Ingelheim. MS reports lecture fee from Novo Nordisk and Boehringer Ingelheim.